Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Finance
Global Chiral Technology Market 2013-2017

Global chiral technology market: 14.5% CAGR forecast between 2013-17


Print article Print article
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2014-04-04 15:03:04 - Global Chiral Technology Market 2013-2017 - a new market research report on companiesandmarkets.com

The Global Chiral Technology market is to grow at a CAGR of 14.53 percent over the period 2013-2017. One of the key factors contributing to this market growth is the favorable governmental regulations. The Global Chiral Technology market has also been witnessing the increasing outsourcing of pharmaceutical production to the APAC Region. However, the complexity of chiral chemistry could pose a challenge to the growth of this market.

Many global pharmaceutical companies are nowadays facing several challenges such as patent expirations and pricing pressures. As a result, these companies are on the lookout for cost containment measures. For instance, drug manufacturing in Asian countries is less expensive than it is in western countries. Further, the growing prominence of Asia as an

 

 

end-user market and its growth in terms of manufacturing as well as human resource capabilities is expected to contribute to the growth of the market during the forecast period.

Governmental regulations that support the use of chiral technology constitute a major driver in this market. Healthcare authorities in many countries have introduced guidelines and policies that provide incentives for investments made in developing single enantiomer drugs.

One of the main challenges in this market is the complexity of chiral chemistry. The complexity of chiral chemistry is higher in the case of molecules containing multiple chiral centers. As a result, the selection of an appropriate technique for the synthesis and resolution of such molecules becomes challenging.

Key vendors dominating this space include BASF SE, Daicel Corp. Royal DSM N.V.

Other vendors mentioned are Bachem Holding AG, Cambrex Corp.,Codexis Inc.,Johnson Matthey plc, Novasep Inc., Phenomenex Inc., Regis Technologies Inc., Solvias AG, Strem Chemicals Inc..

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com